ImageneBio (IMA) Gains from Investment Securities (2020 - 2024)
Historic Gains from Investment Securities for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to $1.2 million.
- ImageneBio's Gains from Investment Securities changed N/A to $1.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.1 million, marking a year-over-year increase of 2100.0%. This contributed to the annual value of -$99000.0 for FY2024, which is 10139.67% down from last year.
- Per ImageneBio's latest filing, its Gains from Investment Securities stood at $1.2 million for Q4 2024.
- ImageneBio's 5-year Gains from Investment Securities high stood at $8.3 million for Q2 2024, and its period low was -$778000.0 during Q3 2020.
- In the last 5 years, ImageneBio's Gains from Investment Securities had a median value of $5.0 million in 2021 and averaged $3.9 million.
- As far as peak fluctuations go, ImageneBio's Gains from Investment Securities skyrocketed by 91081.08% in 2021, and later tumbled by 10129.47% in 2024.
- Quarter analysis of 5 years shows ImageneBio's Gains from Investment Securities stood at -$148000.0 in 2020, then soared by 910.81% to $1.2 million in 2021, then surged by 458.45% to $6.7 million in 2022, then increased by 14.1% to $7.6 million in 2023, then crashed by 84.46% to $1.2 million in 2024.
- Its last three reported values are $1.2 million in Q4 2024, $8.2 million for Q3 2024, and $8.3 million during Q2 2024.